What is regulatory compliance and why is it important in the pharmaceutical industry?
The Pharmaceutical Industry deals with manufacturing and marketing of pharmaceuticals, biological products, and medicinal devices, used for the diagnosis and treatment of diseases in addition to conducting research for the development of new products for human welfare. Its focus is patient and public health so, it is critical to maintain the quality of the final products to prevent health hazard. Thus, if products are not of suitable quality, then they may result in severe adverse effects or even death of the consumer or patient.
The
pharmaceutical industry is a highly regulated industry.
Pharmaceutical regulation is designed to ensure safety, efficacy, and quality
of the drugs available to consumers and patients. Regulatory compliance is a
driving force within the pharmaceutical industry, and it is ever evolving to
ensure patient safety. Pharma Regulatory Affairs is a department in a pharmaceutical company
that ensures that its organization follows all of the regulations and laws
pertaining to drug research and development companies. Regulatory Affairs plays a crucial role in the pharmaceutical
industry, especially during drug development, which is a lengthy, complex, and
extremely costly process. A range of regulatory activities over the
course of a drug's life is carried out- including premarket screening and
evaluation of new pharmaceuticals, inspection of manufacturing facilities,
regulation of drug labeling and promotional activities, and the post marketing
surveillance of drugs.
Regulatory compliance can be defined as certain standards and rules which are set forth by different regulatory bodies on a national and international level. This helps in ensuring that an association is adhering to the principles and essential requirements which is important to safeguard public health. Maintaining regulatory compliance with regulations is essential for successful product approval. Non-compliance refers to the situation wherein a product does not meet the requirements specified by the regulatory authorities. These could be a range of situations such as a deviation in a process, design, documentation, or procedure that may negatively affect the product quality.
Regulatory non-compliance can have a
profound negative impact on a pharma company’s finances, reputation, and
customers. The consequences of
non-compliance can be harsh- not only can it delay products from getting into
the market but it can also lead to product recall from the market. This can be
a heavy cost burden for the pharmaceutical organization. Furthermore, non-compliance
can also lead to criminal and civil penalties including fines and arrest
against individuals and corporation which can create negative reputation in the
market. Given the high stakes
involved, pharmaceutical companies must ensure that they comply with all
relevant regulations.
Conclusion
Pharmaceutical regulatory compliance is a
relatively time-and resource-consuming work for pharmaceutical company. A Regulatory consulting
company can guide and assist pharmaceutical, biotech and healthcare companies
in the design and implementation of innovative and global regulatory strategies
to expedite product development and registration of drugs, biologics, medical
devices, combination products, and other healthcare products while maintaining
compliance. They can provide regulatory service and support for products in all stages of development
(preclinical to post-market) and help companies to bring products to the market
in the most efficient and cost-effective manner, within an evolving and
increasingly challenging regulatory environment.
For more detail visit at
Comments
Post a Comment